Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Finnish evidence-based guideline for open-angle glaucoma.

A Tuulonen1, P J Airaksinen, E Erola

  • 1Department of Ophthalmology, University of Oulu, FIN-90014 Oulu, Finland.

Acta Ophthalmologica Scandinavica
|March 13, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Finnish Healthcare Professionals' Online Searches for Paediatric Oral Antibiotics: COVID-19 Impact, 2017-2023.

Acta paediatrica (Oslo, Norway : 1992)·2025
Same author

Users of reimbursed glaucoma medications in Finland in 1986-2023: A nationwide study.

Acta ophthalmologica·2024
Same author

The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.

Translational medicine @ UniSa·2019
Same author

Community Health Centre-Based Outreach Clinic for undergraduate dental education: Experience in Helsinki over 8 years.

European journal of dental education : official journal of the Association for Dental Education in Europe·2017
Same author

Contacting co-culture of human retinal microvascular endothelial cells alters barrier function of human embryonic stem cell derived retinal pigment epithelial cells.

Experimental cell research·2017
Same author

Serum carotenoid and tocopherol concentrations and risk of asthma in childhood: a nested case-control study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Chronic open-angle glaucoma management requires intensive monitoring, especially with high intraocular pressure (IOP). The primary treatment goal is preventing optic nerve damage, not just lowering IOP.

Area of Science:

  • Ophthalmology
  • Glaucoma Research

Background:

  • Chronic open-angle glaucoma is typically slow-progressing, but high intraocular pressure (IOP > 30 mmHg) necessitates intensive management.
  • Lowering IOP is the primary therapeutic strategy, though preventing glaucomatous damage is the ultimate goal.

Framework:

  • Treatment effectiveness is evaluated through optic disc imaging, retinal nerve fiber layer analysis, and visual field testing.
  • Progressive glaucomatous changes mandate escalating treatment intensity.

Implementation:

  • Close monitoring is crucial, recognizing that structural and functional changes may manifest with significant delays (up to several years).
  • Accurate assessment of abnormalities requires specialized examination techniques and considerable examiner expertise.

Related Experiment Videos

Implications:

  • Key risk factors for glaucoma include elevated IOP, advanced age, family history, exfoliation syndrome, race, and myopia.
  • Understanding these factors and monitoring progression are vital for effective glaucoma patient care.